ATLASARK Genomic Revolution ETF (ARKG): outlook, holdings and fees
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund and is managed by ARK ETF Trust. The expense ratio is 0.71% and the yield is 0.00%. The ten largest holdings are 58% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on ARKG
| Last price | $49.13 (-4.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 48% |
| Likely 1-month range (50%) | $44.23 – $53.76 |
| Normal 1-day range (±1σ) | ±3.3% |
| Distribution yield | 0.00% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
ARKG fund facts
| Issuer | ARK ETF Trust |
|---|---|
| Theme | Technology & innovation |
| Assets under management | $2.1B |
| Expense ratio | 0.71% |
| Number of holdings | 33 |
| Portfolio turnover | 29% |
| Inception | Oct 31, 2014 |
| Exchange | CBOE |
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.
ARKG top holdings
| Holding | Sector | Weight |
|---|---|---|
| 10X Genomics Inc TXG | Healthcare | 9.37% |
| Twist Bioscience Corp TWST | Healthcare | 8.83% |
| Tempus AI, Inc. Class A Common Stock TEM | Healthcare | 7.96% |
| Crispr Therapeutics AG CRSP | Healthcare | 5.32% |
| Absci Corp ABSI | Healthcare | 4.89% |
| Illumina Inc ILMN | Healthcare | 4.65% |
| Natera Inc NTRA | Healthcare | 4.64% |
| Guardant Health Inc GH | Healthcare | 4.65% |
| CareDx Inc CDNA | Healthcare | 4.17% |
| Personalis Inc PSNL | Healthcare | 3.72% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
ARKG sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 92.3%, Europe Developed 5.2%, United Kingdom 2.6%.
ARKG returns and risk
| Year to date | +74.1% |
|---|---|
| 1 year | +62.8% |
| 3 years (annualised) | +25.1% |
| 5 years (annualised) | -6.4% |
| 10 years (annualised) | +10.8% |
| Volatility (3 years) | 42.1% |
| Sharpe ratio (3 years) | 0.63 |
Past returns do not guarantee future results.
ARKG: frequently asked questions
What does ARKG invest in?
ARK Genomic Revolution ETF invests in a portfolio of securities. Its largest holdings are 10X Genomics Inc (9.4%), Twist Bioscience Corp (8.8%), Tempus AI, Inc. Class A Common Stock (8.0%), Crispr Therapeutics AG (5.3%), Absci Corp (4.9%).
What is the ARKG expense ratio?
0.71% a year: about $71.00 for every $10,000 invested.
What is the ARKG dividend yield?
0.00%. ATLAS does not hold the exact distribution dates for ETFs.
Will ARKG go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 48%, with a likely range (50%) of $44.23 to $53.76 from $49.13 today. It is a probability, not a prediction.
How has ARKG performed?
Year to date +74.1%, one year +62.8%, three years +25.1% a year, five years -6.4% a year. Past returns do not guarantee future results.
Similar ETFs: Technology & innovation
- Vanguard Information Technology ETF (VGT)
- State Street Technology Select Sector SPDR ETF (XLK)
- iShares U.S. Technology ETF (IYW)
- Fidelity MSCI Information Technology Index ETF (FTEC)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- iShares A.I. Innovation and Tech Active ETF (BAI)
- iShares Expanded Tech Sector ETF (IGM)
Educational information, not investment advice. Disclaimer